QuickView for posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (biogroup)

1. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
2. S. cerevisiae exponential cultures; nitrogen sources shifted between proline and glutamine
3. HeLa cells synchronized then released from S and mitosis phases
4. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

There were no matches for posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery

There were no clinical trials for posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery